Observational studyYonsei medical journal2026
Stroke Recurrence and Long-Term Mortality in Patients Diagnosed with Cancer Following Stroke.
Observational study in Yonsei medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSystemic cancer and ischemic stroke are major causes of mortality and share several risk factors, including older age, smoking, obesity, and inflammation. This study investigated the incidence of newly diagnosed cancers in stroke survivors and their outcomes. MATERIALS AND
methodsThis retrospective observational study included patients with acute ischemic stroke enrolled between January 2010 and December 2019. We excluded patients with active or newly diagnosed cancer within 30 days of stroke onset. Primary outcomes were the incidence of new systemic cancer, recurrent ischemic stroke, and mortality.
resultsA total of 5048 patients were included and followed for a median of 3.4 years (interquartile range 1.5-6.1 years). Among them, 242 (4.79%) were diagnosed with a new cancer, and 524 (10.4%) died during follow-up. At the time of cancer diagnosis, 48 patients (19.8%) had metastases. Factors associated with cancer occurrence included male sex [sub-distribution hazard ratio (SHR), 1.84; 95% confidence interval (CI), 1.27-2.67] and older age (SHR, 1.03; 95% CI, 1.01-1.04). During follow-up, 398 patients (7.9%) developed recurrent stroke, with a higher incidence in those with cancer than those without (14.9% vs. 7.5%,
conclusionCancer frequently developed in stroke survivors. Patients who developed cancer had a higher risk of mortality. Efforts for early cancer detection are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.